Adjunct Research Assistant Professor, Internal Medicine, Diabetes and Lipids
N/A
School of Medicine
Adjunct Research Faculty
Qualification | Year | Awarding Institution | Department |
Degree of Medical School | 2003 | Aristotle University of Thessaloniki | Medical School |
Master | 2006 | Aristotle University of Thessaloniki | Medical School |
PhD | 2011 | Aristotle University of Thessaloniki | Medical School |
Period of employment | Employer | Location | Position | |
From | To | |||
May 2010 | November 2010 | University of London | London, UK | Clinical Research Fellow |
September 2014 | August 2015 | 2nd Propedeutic Department of Internal Medicine, Hippokration University Hospital | Thessaloniki, Greece | Academic Fellow |
October 2018 | ongoing |
1st Department of Internal Medicine, AHEPA University Hospital Diabetes, Endocrinology and Metabolism Division |
Thessaloniki, Greece | Academic Fellow |
Year | Title | Other authors | Journal and Publisher / Conference |
Vol. | Pages |
2019 |
Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials. |
Sahebkar A, Simental-Mendía LE, Katsiki N, Reiner Ž, Banach M, Pirro M, Atkin SL. |
BMJ Open | epub | |
2019 |
Semaglutide as a promising antiobesity drug. |
Christou GA, Katsiki N, Blundell J, Fruhbeck G, Kiortsis DN. | Obes Rev | epub | |
2019 |
Effects of lipid lowering drugs on arterial stiffness. One more way to reduce cardiovascular risk? |
Reklou A, Katsiki N, Karagiannis A, Athyros V. |
Curr Vasc Pharmacol |
epub | |
2019 |
Fibroblast growth factor 21: A role in cardiometabolic disorders and cardiovascular risk prediction? |
Katsiki N, Mantzoros C. | Metabolism | epub | |
2019 | Dietary natural products as emerging lipoprotein(a)-lowering agents | Momtazi-Borojeni AA, Katsiki N, Pirro M, Banach M, Rasadi KA, Sahebkar A. |
J Cell Physiol. |
epub | |
2018 |
Are we ready for a gender-specific approach in interventional cardiology? |
Calabrò P, Niccoli G, Gragnano F, Grove EL, Vergallo R, Mikhailidis DP, Patti G, Spaccarotella C, Katsiki N, Masiero G, Ueshima D, Pinar E, Chieffo A, Ussia GP, Eitel I, Tarantini G; Working Group of Interventional Cardiology of the Italian Society of Cardiology |
Int J Cardiol | epub | |
2018 |
The future of febuxostat after the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES) trial: who CARES? |
Katsiki N, Borghi C. | Expert Opin Pharmacother | epub | |
2018 | Lipids: a personal view of the past decade. | Katsiki N, Mikhailidis DP. | Hormones | 17(4) | 461-478. |
2018 |
Contrast-induced acute kidney injury in diabetes mellitus: Clinical relevance and predisposing factors. Could statins be of benefit? |
Katsiki N, Fonseca V, Mikhailidis DP. | J Diabetes Complications. | 32(11) | 982-984 |
2018 |
Fifteen years of LIFE (Losartan Intervention for Endpoint Reduction in Hypertension)-Lessons learned for losartan: An "old dog playing good tricks" |
Katsiki N, Tsioufis K, Ural D, Volpe M. | J Clin Hypertens (Greenwich). | epub |
Date | Title | Funded by | Project Role* |
2014 | Phase III Clinical Trial on A Hypolipidemic Drug | Pharmaceutical company | Researcher |
2016 | Phase III Clinical Trial on A Hypolipidemic Drug | Pharmaceutical company | Researcher |
Ongoing | Observational study on dyslipidemia | Pharmaceutical company | Researcher |
Ongoing | Observational study on type 2 diabetes mellitus | Pharmaceutical company | Researcher |
Period | Organization | Title of Position or Service |
2017-2018 | Hellenic Atherosclerosis Society | Member of the Executive Board |
2018 - ongoing | Hellenic Atherosclerosis Society | Member of the Executive Board |
Date | Title | Awarded by: |
2015 | Fellowship of Excellence | Aristotle University of Thessaloniki |
2009 | Award of best oral presentation | Northern Greece Diabetes Association |
2009 | Award of best poster presentation | Hellenic Association for the Study of Diabetes |
2008 | PhD fellowship | Northern Greece Diabetes Association |